2017
DOI: 10.1007/s10549-017-4363-9
|View full text |Cite
|
Sign up to set email alerts
|

The effects of physical activity and fatigue on cognitive performance in breast cancer survivors

Abstract: Findings suggest that MVPA may be associated with greater executive function and working memory in BCSs. Further, this effect may be partially indirect through cancer-related symptoms (e.g., fatigue). Results emphasize the need for additional scientific investigation in the context of prospective and efficacy trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
53
0
1

Year Published

2018
2018
2020
2020

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 48 publications
(55 citation statements)
references
References 43 publications
1
53
0
1
Order By: Relevance
“…Finally, the potential interrelatedness of these domains highlights an opportunity for interventions to preserve both physical and cognitive function. There is some evidence that physical activity is helpful in treating CRCI; however, research evaluating the impact of physical activity on objectively measured cognitive function and in patients during the acute phase of cancer treatment is needed.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, the potential interrelatedness of these domains highlights an opportunity for interventions to preserve both physical and cognitive function. There is some evidence that physical activity is helpful in treating CRCI; however, research evaluating the impact of physical activity on objectively measured cognitive function and in patients during the acute phase of cancer treatment is needed.…”
Section: Discussionmentioning
confidence: 99%
“…We conducted a pooled analysis of 753 breast cancer survivors from two observational studies (study 1: n = 440 and study 2: n = 313) for a total sample size of 753 in the present analysis. Full details on study 1 and study 2 can be found in previously published manuscripts of the studies main aims. For the current analysis, participants from both studies were included if they had accelerometer data with at least four valid days, defined as at least 10 hours of accelerometer wear time for each day, and complete data on demographic and QOL outcome assessment .…”
Section: Methodsmentioning
confidence: 99%
“…Much of the previous research on CACD has examined factors that differ between persons such as treatment modality, cognitive reserve, symptomatology (eg, fatigue and depression), and genetic polymorphisms . These between‐person differences in risk factors, however, are only inconsistently associated with performance on traditional neuropsychological testing.…”
Section: Introductionmentioning
confidence: 99%